Andrew McNicol, MD
Interventional Pain Medicine · Mount Vernon, OHNPI 1649701590
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,850 of the $3,436 with a category attached, or 82.9%. 9 manufacturers reported payments, led by Medtronic at 50.8% of the total. Reporting peaked in 2022 at $1,121 and has fallen 68.6% since, to $352 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in OH, where the typical reported total is $5,193.
Across 61 payments — averaging $56.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Nevro Corp.$678
- Curonix LLC$326
- Saluda Medical Americas, Inc.$307
- Abbott$189
- Globus Medical$125
- plus $65 from 3 others
What the payments were for
- Travel & lodging$58717%
- Food & beverage$2,85083%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 20 | $1,747 |
| Nevro Corp. | 16 | $678 |
| Curonix LLC | 5 | $326 |
| Saluda Medical Americas, Inc. | 9 | $307 |
| Abbott | 4 | $189 |
| Globus Medical | 4 | $125 |
| Boston Scientific | 1 | $26 |
| Stryker | 1 | $20 |
| Averitas Pharma Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,436 in reported general payments places this provider in the 35th percentile of 67 interventional pain medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 300 | $8,143 |
| Pregabalin | 276 | $4,629 |
| Gabapentin | 323 | $4,163 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 278 | $4,124 |
| Duloxetine Hcl | 147 | $3,405 |
| Lidocaine | 53 | $3,162 |
| Celecoxib | 86 | $2,552 |
| Methocarbamol | 120 | $1,537 |
| Naloxone Hcl | 19 | $1,203 |
| Diclofenac Sodium | 87 | $1,117 |
| Baclofen | 127 | $856 |
| Diclofenac Potassium | 19 | $765 |
| Cyclobenzaprine Hcl | 35 | $692 |
| Oxycodone Hcl | 69 | $679 |
| Memantine Hcl | 15 | $485 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Mount Vernon
- Gladstone McDowellColumbus$660K
- Humam AkbikFairfield$116K
- Sara NashiCincinnati$116K
- Jaudat MahmoodKent$97K
- Omar AliSpringfield$67K
- Dustin ReynoldsWesterville$61K
- James OttingToledo$47K
- Mark MalinowskiChillicothe$39K
- David WalegaColumbus$37K
- Ronald LinehanLancaster$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.